Prevalence and risk factors for nausea and vomiting in breast cancer patients undergoing chemotherapy

Key Points

• The aim is to determine the prevalence and risk factors for chemotherapy-induced nausea and vomiting in breast cancer patients.
• Conducted a meta-analysis focusing on the Asian population.
• Identified risk factors including younger age, history of motion sickness, and number of chemotherapy cycles.
• Analyzed data related to chemotherapy-induced nausea and vomiting.
• High prevalence of chemotherapy-induced nausea and vomiting among breast cancer patients identified.
• Younger age, history of motion sickness, and three or more chemotherapy cycles are significant risk factors.
• Targeting identified risk factors may offer potential prevention strategies.